LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 185

Search options

  1. Article ; Online: Iva Vukušić

    Petrović Vladimir

    Comparative Southeast European Studies, Vol 71, Iss 3, Pp 448-

    Serbian Paramilitaries and the Breakup of Yugoslavia. State Connections and Patterns of Violence

    2023  Volume 450

    Keywords History (General) and history of Europe ; D ; Political science ; J
    Language English
    Publishing date 2023-09-01T00:00:00Z
    Publisher De Gruyter
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Evaluation of the diagnostic utility of case definitions to detect influenza virus infection in Vojvodina, Serbia

    Ristić Mioljub / Petrović Vladimir

    Srpski Arhiv za Celokupno Lekarstvo, Vol 148, Iss 1-2, Pp 100-

    2020  Volume 105

    Abstract: Introduction/Objective. A case definition recommended by the World Health Organization is commonly used for influenza surveillance worldwide. The aim of this study was to evaluate prognostic values of proposed case definitions of Influenza Like Illness ( ... ...

    Abstract Introduction/Objective. A case definition recommended by the World Health Organization is commonly used for influenza surveillance worldwide. The aim of this study was to evaluate prognostic values of proposed case definitions of Influenza Like Illness (ILI), Severe Acute Respiratory Illness (SARI) and Acute Respiratory Distress Syndrome (ARDS) for laboratory confirmed-influenza and to compare the age distribution of influenza patients across virus types and subtypes in Vojvodina. Methods. We conducted a descriptive epidemiological study using surveillance reports and laboratory data from October 1, 2010 to May 20, 2017 (seven surveillance seasons). Results. We included 2,937 participants, 48.6% of whom were laboratory-confirmed influenza cases, and most of the confirmed cases (30.1%) were detected in February. In the 15–29 years age group, the type A influenza (H3N2) was more frequent among patients with ILI (54.9% vs. 34.2%, p = 0.040), and less frequent in patients with SARI (39.4% vs. 65.8%, p = 0.009) compared with influenza type B. In patients aged 30–64 years with ARDS, influenza type B was more common than influenza type A (H3N2) (13.4% vs. 6.2%, p = 0.032), but less common in compared to influenza type A (H1N1) pdm09 (13.4% vs. 25.7%, p = 0.017). The SARI case definition of influenza was associated with an increased likelihood of laboratoryconfirmed influenza for all age groups (p < 0.05). During the epidemic period, it was observed that the ILI case definition had the highest diagnostic value for influenza in the age group 5–14 (AUC = 0.733; 95% CI: 0.704–0.764), while the SARI and ARDS case definitions were the best predictors of influenza for patients 15–29 years of age (AUC = 0.565; 95% CI: 0.504–0.615 and AUC = 0.708; 95% CI: 0.489–0.708, respectively). The case definition of ARDS had the maximum sensitivity (100%) among patients 15–29 years of age. Conclusion. The proposed case definitions of influenza appeared to be good predictors of influenza and therefore can be useful for influenza surveillance, especially in the countries with limited laboratory capacities.
    Keywords influenza virus ; epidemiology ; virology ; case definition ; surveillance ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2020-01-01T00:00:00Z
    Publisher Serbian Medical Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023).

    Vuković, Vladimir / Patić, Aleksandra / Ristić, Mioljub / Kovačević, Gordana / Hrnjaković Cvjetković, Ivana / Petrović, Vladimir

    Viruses

    2024  Volume 16, Issue 2

    Abstract: This study aimed to estimate the serological status and dynamic changes in the prevalence of Parvovirus B19 (PVB19) antibodies within the general population residing in the northern part of the Republic of Serbia (Province of Vojvodina) during a 16-year ... ...

    Abstract This study aimed to estimate the serological status and dynamic changes in the prevalence of Parvovirus B19 (PVB19) antibodies within the general population residing in the northern part of the Republic of Serbia (Province of Vojvodina) during a 16-year period. Serum samples were analyzed for Human PVB19-specific IgM and IgG antibodies using enzyme-linked immunosorbent assay (ELISA). Throughout the study period, the overall seroprevalence was 49.51%. Approximately 10% of patients exhibited a serologic profile positive for PVB19 IgM antibodies. Notably, seroprevalence varied significantly, ranging from 9.12% in the pediatric cohort (ages 1-4 years) to 65.50% in the adult demographic (40-59 years old). Seroprevalence was higher (51.88%) among women compared to men (42.50%). Immunologically naive pregnant women in the age groups 26-36 and 36-45 years had 45% (OR = 0.55, 95% CI: 0.31-1.00) and 52% (OR = 0.48; 95% CI: 0.24-0.94) lower odds of having negative IgM and IgG compared to those in age group 16-25 years old. Improved knowledge of the epidemiology of PVB19 may assist clinicians in the differential diagnosis of PVB19 clinical manifestations. The PVB19 detection is particularly important for monitoring individuals in risk groups such as women of reproductive age, medical staff, patients with hematological disorders, and those with immunodeficiency.
    MeSH term(s) Male ; Adult ; Humans ; Female ; Child ; Pregnancy ; Adolescent ; Young Adult ; Middle Aged ; Erythema Infectiosum/epidemiology ; Seroepidemiologic Studies ; Yugoslavia ; Serbia/epidemiology ; Parvoviridae Infections/epidemiology ; Parvoviridae Infections/diagnosis ; Parvovirus B19, Human ; Antibodies, Viral ; Immunoglobulin G ; Immunoglobulin M
    Chemical Substances Antibodies, Viral ; Immunoglobulin G ; Immunoglobulin M
    Language English
    Publishing date 2024-01-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v16020180
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Seroprevalence Study of Anti-HBs Antibodies in the General Population of Vojvodina, Serbia.

    Rajčević, Smiljana / Medić, Snežana / Patić, Aleksandra / Dragnić, Nataša / Ristić, Mioljub / Vuković, Vladimir / Petrović, Vladimir

    Medicina (Kaunas, Lithuania)

    2024  Volume 60, Issue 3

    Abstract: Background and ... ...

    Abstract Background and Objectives
    MeSH term(s) Male ; Humans ; Female ; Child ; Adolescent ; Young Adult ; Adult ; Infant ; Child, Preschool ; Middle Aged ; Hepatitis B Surface Antigens ; Serbia/epidemiology ; Yugoslavia ; Seroepidemiologic Studies ; Hepatitis B Antibodies ; Hepatitis B/epidemiology ; Hepatitis B/prevention & control
    Chemical Substances Hepatitis B Surface Antigens ; Hepatitis B Antibodies
    Language English
    Publishing date 2024-03-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2188113-3
    ISSN 1648-9144 ; 1010-660X
    ISSN (online) 1648-9144
    ISSN 1010-660X
    DOI 10.3390/medicina60030436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged ≥60 Years in Vojvodina, Serbia.

    Petrović, Vladimir / Vuković, Vladimir / Marković, Miloš / Ristić, Mioljub

    Vaccines

    2022  Volume 10, Issue 3

    Abstract: Real-world evidence of the vaccine effectiveness (VE) of different COVID-19 vaccines is needed in order to better shape vaccine recommendations and policies and increase vaccine acceptance, especially among vulnerable populations such as the elderly. We ... ...

    Abstract Real-world evidence of the vaccine effectiveness (VE) of different COVID-19 vaccines is needed in order to better shape vaccine recommendations and policies and increase vaccine acceptance, especially among vulnerable populations such as the elderly. We analyzed the early effectiveness of four COVID-19 vaccines, namely BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 in population aged ≥60 years for symptomatic, mild and severe COVID-19, in the period January-April 2021 in Vojvodina, a northern province of Serbia. Incidence rates of SARS-CoV-2 infection were calculated using data from the provincial COVID-19 surveillance registry, and vaccination coverage data were obtained from the nationwide registry of administered COVID-19 vaccines. During the observation period, 134,535 subjects aged ≥60 years were fully vaccinated, of whom 87.7% received BBIBP-CorV, 7.1% BNT162b2 and 5.2% Gam-COVID-Vac vaccines. The estimated VE in fully vaccinated persons was 86.9% (95% CI, 86-87.7) for BBIBP-CorV, 95% (95% CI, 92.4-96.7) for Gam-COVID-Vac and 99% (95% CI, 97.8-99.5) for BNT162b2, while VE after the first dose of ChAdOx1 nCoV-19 was 88.6% (95% CI, 80.5-93.4). Estimates were similar when stratifying the analyses to severe and mild SARS-CoV-2 infections. Our analysis provides evidence of high early effectiveness of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 in elderly people in preventing symptomatic, severe and mild COVID-19 disease, particularly after being fully vaccinated.
    Language English
    Publishing date 2022-03-03
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10030389
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book: Zdravstveno stanje stanovništva grada Novog Sada 2013. godine

    Petrović, Vladimir

    2014  

    Author's details glavni i odgovorni urednik, dr Vladimir Petrović
    MeSH term(s) Health Status ; Health Status Indicators ; Urban Health/statistics & numerical data
    Keywords Serbia
    Language Serbian
    Size 112 pages :, illustrations +
    Document type Book
    Accompanying material 1 CD-ROM (4 3/4 in.)
    ISBN 9788686185440 ; 8686185444
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  7. Article: Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study.

    Petrović, Vladimir / Vuković, Vladimir / Patić, Aleksandra / Marković, Miloš / Ristić, Mioljub

    Vaccines

    2022  Volume 11, Issue 1

    Abstract: Many available SARS-CoV-2 vaccines demonstrated good humoral response, but studies directly comparing their immunogenicity in the general population are lacking. We evaluated the medium−term kinetics of anti-S SARS-CoV-2 antibodies (Abs) at one and six ... ...

    Abstract Many available SARS-CoV-2 vaccines demonstrated good humoral response, but studies directly comparing their immunogenicity in the general population are lacking. We evaluated the medium−term kinetics of anti-S SARS-CoV-2 antibodies (Abs) at one and six months after the second dose of BNT162b2, BBIBP-CorV, and Gam-COVID-Vac. Immunogenicity at six months was directly compared between BNT162b2, BBIBP-CorV, Gam-COVID-Vac, and ChAdOx1 nCoV-19. Participants ≥ 20 years old from Novi Sad, Serbia, without prior SARS-CoV-2 infection, were included. Anti S1/S2 IgG antibodies were measured using quantitative LIAISON SARS-CoV-2 assay. A total of 368 participants were included: 231 (62.77%) had sera collected at two time points. Two doses of BNT162b2 were received by 37.50% of participants, followed by BBIBP-CorV (22.01%), Gam-COVID-Vac (21.47%), and ChAdOx1 nCoV-19 (19.02%). Mean Ab levels at the 28th day and 6 months were 216.55 (SD = 105.73) AU/mL and 75.68 (SD = 57.30) for BNT162b2, 194.38 (SD = 140.24) and 90.53 (SD = 111.30) for Gam-COVID-Vac, and 72.74 (SD = 80.04) and 24.43 (SD = 38.43) for BBIBP-CorV group (p < 0.01, between two time points across all three groups), with a significant difference between women and men (p < 0.01, for both sexes). At the sixth month post-vaccination, the highest mean Ab level was detected in Gam-COVID-Vac group (91.28 AU/mL, SD = 95.96), followed by BNT162b2 (85.25 AU/mL, SD = 60.02), ChAdOx1 nCoV-19 (64.22 AU/mL, SD = 65.30), and BBIBP-CorV (25.26 AU/mL, SD = 36.92) (p < 0.01). Anti-spike IgG persistence was demonstrated six months post-vaccination with a significant decline in Ab levels. These results suggest a lower protection against SARS-CoV-2 over time. Our findings support the introduction of additional (booster) doses.
    Language English
    Publishing date 2022-12-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines11010056
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Pneumococcal carriage in adults aged 50 years and older in outpatient health care facility during pandemic COVID-19 in Novi Sad, Serbia.

    Petrović, Vladimir / Ristić, Mioljub / Milosavljević, Biljana / Djilas, Milan / Marković, Miloš

    PloS one

    2022  Volume 17, Issue 10, Page(s) e0274674

    Abstract: Background: Data related to carriage of Streptococcus pneumoniae (Spn) and antimicrobial resistance patterns in middle-aged and older adults are limited. We assessed the carriage of Spn, and its antibiotic resistance patterns, among participants ≥50 ... ...

    Abstract Background: Data related to carriage of Streptococcus pneumoniae (Spn) and antimicrobial resistance patterns in middle-aged and older adults are limited. We assessed the carriage of Spn, and its antibiotic resistance patterns, among participants ≥50 years of age living in the city of Novi Sad during the second year of COVID-19 pandemic.
    Methods: Analysis of prospectively collected data among participants with or without symptoms of upper respiratory tract infection who visited their elected physicians in the Primary Health Care Centre of Novi Sad (outpatient facility) was conducted from May 18, 2021 to December 7, 2021. Both nasopharyngeal (NP) and oropharyngeal (OP) samples from each participant were collected.
    Results: A total of 1042 samples from 521 study subjects (1 NP and 1 OP sample from each person) were collected. Sixteen samples from the same number of persons (3.1%, 95% confidence interval: 1.76%-4.94%) were culture positive for the presence of Spn. Overall, the median age of study participants was 71 years (range, 50-93 years; 90th percentile, 77 years), and most (197/521, 37.8%) of them were 70-79 years of age. A majority of the study subjects were: females (324/521; 62.2%), sampled during May and June 2021 (376/521, 72.2%), those who did not have contact with children aged 0-10 years in the family (403/521; 77.4%), without smokers in the household (443/521; 85.0%), and those who did not receive vaccine against Spn (519/521; 99.6%). Out of 16 Spn positive samples, for six participants, Spn carriage serotypes were obtained and there were four vaccine (6A, 11A, 15B, and 18C) serotypes, and two (6C and 35F) non-vaccine serotypes. Remaining 10 (62.50%) samples were non-typeable isolates of pneumococci. Among four vaccine serotypes, two (6A and 18C) were represented in PCV13, and 18C along with the other two (11A and 15B) in PPSV23 vaccine. The highest level of resistance of Spn isolates was observed for erythromycin, (10 or 62.50%), and tetracycline, (7 or 43.75%), one isolate showed resistance to penicillin, ampicillin, and amoxicillin/amoxicillin-clavulanic acid, while none of them were resistant to ceftriaxone, trimethoprim/sulfamethoxazole and levofloxacin. There were three multi-drug resistant isolates; one was identified as 6C (non-vaccine serotype), and two other were non-typeable isolates of Spn.
    Conclusions: In this first study conducted in Serbia on Spn carriage in adults ≥50 years of age, we found low prevalence of Spn carriage and identified 6 serotypes of Spn, four of which were represented in vaccines. These results may support future Spn colonization studies among middle-aged and older adults.
    MeSH term(s) Aged ; Aged, 80 and over ; Amoxicillin-Potassium Clavulanate Combination ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; COVID-19/epidemiology ; Carrier State/epidemiology ; Ceftriaxone ; Child ; Delivery of Health Care ; Erythromycin ; Female ; Humans ; Infant ; Levofloxacin ; Middle Aged ; Nasopharynx ; Outpatients ; Pandemics ; Penicillins ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines ; Serbia/epidemiology ; Serogroup ; Streptococcus pneumoniae ; Tetracyclines ; Trimethoprim, Sulfamethoxazole Drug Combination
    Chemical Substances Anti-Bacterial Agents ; Penicillins ; Pneumococcal Vaccines ; Tetracyclines ; Erythromycin (63937KV33D) ; Levofloxacin (6GNT3Y5LMF) ; Amoxicillin-Potassium Clavulanate Combination (74469-00-4) ; Ceftriaxone (75J73V1629) ; Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2)
    Language English
    Publishing date 2022-10-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0274674
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia.

    Ristić, Mioljub / Vuković, Vladimir / Patić, Aleksandra / Marković, Miloš / Petrović, Vladimir

    Vaccines

    2022  Volume 10, Issue 12

    Abstract: Healthcare workers (HCWs) are a vulnerable and critical population in the ongoing response to the SARS-CoV-2 pandemic. We aimed to estimate the seroprevalence in HCWs considering all of their previous contacts with the SARS-CoV-2 virus and/or the ... ...

    Abstract Healthcare workers (HCWs) are a vulnerable and critical population in the ongoing response to the SARS-CoV-2 pandemic. We aimed to estimate the seroprevalence in HCWs considering all of their previous contacts with the SARS-CoV-2 virus and/or the immunity acquired through their immunization against COVID-19 before the advent of the Omicron variants BA.4/BA.5. Serum samples were collected from 28 March to 10 June 2022. We covered 25% out of all the people who worked in some of the government healthcare centers (primary, secondary, and tertiary level) across the entire Autonomous Province of Vojvodina (Northern Serbia). Two serological tests (Anti-SARS-CoV-2 QuantiVac ELISA and LIAISON® SARS-CoV-2 TrimericS) were used to detect anti-spike IgG antibodies. The overall prevalence of the SARS-CoV-2 antibody among the 6936 HCWs was 92.96% [95% CI 92.33−93.55]. Regarding the type of serological test, there was a statistically significant (p = 0.0079) difference of the seropositivity obtained by the LIAISON® SARS-CoV-2 TrimericS (93.87%, 95% CI 92.97−94.69) and Anti-SARS-CoV-2 QuantiVac ELISA (92.23%, 95% CI 91.34−93.06) tests. Seropositivity to SARS-CoV-2 significantly (p < 0.0001) increased with the number of SARS-CoV-2 infections combined with the number of doses of the SARS-CoV-2 vaccines received. A vast majority of the HCWs in Vojvodina had detectable levels of antibodies to the spike protein of SARS-CoV-2, but despite this high seropositivity, it is unknown whether this herd immunity among HCWs is protective against the new variants of concern. Further research should evaluate the rates of reinfections and the associated severity of COVID-19 caused by the Omicron sublineages and/or new variants of SARS-CoV-2 among HCWs.
    Language English
    Publishing date 2022-12-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines10122168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Pyrazolone-type compounds (part II):

    Branković, Jovica / Milovanović, Vesna M / Petrović, Zorica D / Simijonović, Dušica / Petrović, Vladimir P

    RSC advances

    2023  Volume 13, Issue 5, Page(s) 2884–2895

    Abstract: The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the ... ...

    Abstract The pyrazolone class comprises a variety of hybrid compounds displaying diverse biological actions. Although studied for decades, these compounds are still of interest due to their facile chemical transformations. In our previous work, we presented the synthetic route of functionalised pyrazolone derivatives. The presence of pyrazolone structural motif in many drugs, such as edaravone, prompted us to investigate the antioxidant features of the selected compounds. In this paper, we provide an extensive
    Language English
    Publishing date 2023-01-18
    Publishing country England
    Document type Journal Article
    ISSN 2046-2069
    ISSN (online) 2046-2069
    DOI 10.1039/d2ra08280b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top